Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
CR-1202 by Conaris Research Institute for Unspecified Gastrointestinal Disorders: Likelihood of Approval
CR-1202 is under clinical development by Conaris Research Institute and currently in Phase III for Unspecified Gastrointestinal Disorders. According to...